Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd.

NASDAQ:SLGL

Overview | Financials
Company Name Sol-Gel Technologies Ltd.
Symbol SLGL
Currency USD
Price 0.561
Market Cap 15,619,756
Dividend Yield 0%
52-week-range 0.334 - 1.575
Industry Biotechnology
Sector Healthcare
CEO Dr. Alon Seri-Levy
Website https://www.sol-gel.com

An error occurred while fetching data.

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment

Related Stocks

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

ProPhase Labs, Inc. logo

ProPhase Labs, Inc.

PRPH

0.78 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

1.76 USD

IO Biotech, Inc. logo

IO Biotech, Inc.

IOBT

1.1 USD

Assertio Holdings, Inc. logo

Assertio Holdings, Inc.

ASRT

0.85 USD

DarioHealth Corp. logo

DarioHealth Corp.

DRIO

0.92 USD

Financials

Numbers are in millions USD

Numbers are in millions USD